ARCHIVES

Abraxane and Gemcitabine Improves Overall Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 11 | November 30, 2012

Download PDF Visit The Full Archive

Related Articles

EGFR Inhibitor Shrinks Tumors In Phase I Study of Patients With Treatment-Resistant Mutation

May 30, 2014

Clinical Trials Approved In August 2002 By NCI

September 27, 2002

NCAB Votes To ‘Keep Alive’ Concept For Stage 2 Breast Cancer Fat Trial

February 14, 1986

QOL Of Anemic Patients Improved With Darbepoetin

June 28, 2002

ACOS Survey To Assess Tumor Boards’ Impact On Patient Care

January 24, 1986

High Risk Youth Targeted In Concept Ok’d By Advisors

February 8, 1991